Stay updated on SAF-189s in NSCLC: Phase I/II Clinical Trial
Sign up to get notified when there's something new on the SAF-189s in NSCLC: Phase I/II Clinical Trial page.

Latest updates to the SAF-189s in NSCLC: Phase I/II Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new revision entry v3.6.3 is added to the study record history and v3.6.2 is removed, updating the revision timeline shown on the record.SummaryDifference0.1%

- Check20 days agoChange DetectedNew Revision: v3.6.2 appears in the study's version history, representing an updated release note for the record. The older Revision: v3.6.0 is removed from the current view, indicating the history has been updated to reflect the latest revision.SummaryDifference0.1%

- Check34 days agoChange DetectedExpanded sponsor identification to Fosunpharma (Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.). The study record's QC metadata shows a new version (Revision: v3.6.0), replacing the prior 'Verified' and 'Last known status was' entries from v3.5.5.SummaryDifference3%

- Check41 days agoChange DetectedThe record history now shows a new revision entry: Revision: v3.5.5, and the previous entry Revision: v3.5.4 has been removed. This indicates an updated release in the history log.SummaryDifference0.1%

- Check62 days agoChange DetectedThe study record history now shows the latest revision as v3.5.4, replacing the previous v3.5.3. This reflects an update to the record metadata rather than a substantive change to the trial's content.SummaryDifference0.1%

- Check77 days agoChange DetectedA new revision entry, v3.5.3, was added to the Record History, replacing the earlier v3.5.2. This indicates a small update to the page's release notes presentation.SummaryDifference0.1%

Stay in the know with updates to SAF-189s in NSCLC: Phase I/II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAF-189s in NSCLC: Phase I/II Clinical Trial page.